Items where Salford Author is "Fiorillo, M"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 15.

Article

Fiorillo, M, Ozsvari, B, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529 and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2021, 'High ATP production fuels cancer drug resistance and metastasis : implications for mitochondrial ATP depletion therapy' , Frontiers in Oncology, 11 , p. 740720.
[img]
Preview

Sánchez-Alvarez, R, De Francesco, EM, Fiorillo, M, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529 and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2020, 'Mitochondrial Fission Factor (MFF) inhibits mitochondrial metabolism and reduces breast cancer stem cell (CSC) activity' , Frontiers in Oncology, 10 , p. 1776.
[img]
Preview

Fiorillo, M, Tóth, F, Brindisi, M ORCID: https://orcid.org/0000-0002-5022-9642, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529 and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2020, 'Deferiprone (DFP) targets cancer stem cell (CSC) propagation by inhibiting mitochondrial metabolism and inducing ROS production' , Cells, 9 (6) , e1529.
[img]
Preview

Armentano, B, Curcio, R, Brindisi, M, Mancuso, R, Rago, V, Ziccarelli, I, Frattaruolo, L, Fiorillo, M, Dolce, V, Gabriele, B and Cappello, AR 2020, '5-(carbamoylmethylene)-oxazolidin-2-ones as a promising class of heterocycles inducing apoptosis triggered by increased ROS levels and mitochondrial dysfunction in breast and cervical cancer' , Biomedicines, 8 (2) , e35.
[img]
Preview

Pellegrino, M, Rizza, P, Donà, A, Nigro, A, Ricci, E, Fiorillo, M, Perrotta, I, Lanzino, M, Giordano, C, Bonofiglio, D ORCID: https://orcid.org/0000-0002-4142-0496, Bruno, R, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529, Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382, Sisci, D ORCID: https://orcid.org/0000-0001-6577-1541 and Morelli, C ORCID: https://orcid.org/0000-0002-9407-0805 2019, 'FoxO3a as a positive prognostic marker and a therapeutic target in Tamoxifen-resistant breast cancer' , Cancers, 11 (12) , e1858.
[img]
Preview

Frattaruolo, L ORCID: https://orcid.org/0000-0002-7018-8454, Fiorillo, M, Brindisi, M ORCID: https://orcid.org/0000-0002-5022-9642, Curcio, R, Dolce, V, Lacret, R ORCID: https://orcid.org/0000-0003-1135-3891, Truman, AW ORCID: https://orcid.org/0000-0001-5453-7485, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529, Lisanti, MP and Cappello, AR 2019, 'Thioalbamide, a thioamidated peptide from amycolatopsis alba, affects tumor growth and stemness by inducing metabolic dysfunction and oxidative stress' , Cells, 8 (11) , e1408.
[img]
Preview
[img]
Preview

Fiorillo, M, Tóth, F, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529 and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2019, 'Doxycycline, Azithromycin and vitamin C (DAV) : a potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs)' , Aging, 11 (8) , pp. 2202-2216.
[img]
Preview

Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529, Fiorillo, M and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2019, 'Hallmarks of the cancer cell of origin : comparisons with "energetic" cancer stem cells (e-CSCs)' , Aging, 11 (3) , pp. 1065-1068.
[img]
Preview

Fiorillo, M, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529 and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2019, '“Energetic” cancer stem cells (e-CSCs) : a new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy' , Frontiers in Oncology, 8 (677) .
[img]
Preview
[img]

Fiorillo, M, Sanchez-Alvarez, R, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529 and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2018, 'The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling : implicating TIGAR in somatic resistance to endocrine therapy' , Aging, 10 (12) , pp. 4000-4023.
[img]
Preview

Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529, Ozsvari, B, Fiorillo, M, De Francesco, EM, Bonuccelli, G and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2018, 'A mitochondrial based oncology platform for targeting cancer stem cells (CSCs) : MITO-ONC-RX' , Cell Cycle, 17 (17) , pp. 2091-2100.
[img]
Preview

Fiorillo, M, Peiris-Pagès, M, Sanchez-Alvarez, R, Bartella, L, Di Donna, L, Dolce, V, Sindona, G, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529, Cappello, AR and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2018, 'Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism' , Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1859 (9) , pp. 984-996.
[img]
Preview

Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529, Fiorillo, M and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2017, 'Mitochondrial markers predict recurrence, metastasis and Tamoxifen-resistance in breast cancer patients : early detection of treatment failure with companion diagnostics' , Oncotarget, 2017 (8) , pp. 68730-68745.
[img]

Ozsvari, B, Fiorillo, M, Bonuccelli, G, Cappello, AR, Frattaruolo, L, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529, Trowbridge, R, Foster, R and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2017, 'Mitoriboscins : mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast' , Oncotarget, 2017 (8) , pp. 67457-67472.
[img]
Preview
[img]

Fiorillo, M, Sotgia, F ORCID: https://orcid.org/0000-0003-2826-4529, Sisci, D, Cappello, AR and Lisanti, MP ORCID: https://orcid.org/0000-0003-2034-1382 2017, 'Mitochondrial “power” drives tamoxifen resistance : NQO1 and GCLC are new therapeutic targets in breast cancer' , Oncotarget, 2017 (8) , pp. 20309-20327.
[img]
Preview

This list was generated on Wed Mar 22 00:27:37 2023 UTC.